Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT04826393
Brief Title:
ASP8374 + Cemiplimab in Recurrent Glioma
Official Title:
Phase Ib Trial of ASP8374 and Cemiplimab in Recurrent Malignant Glioma Patients
Study:
NCT04826393
Protocol Section:
NCT04826393